Eric Forman, Vice President and COO at LIXTE BIOTECHNOLOGY HOLDINGS, INC. (LIXT), bought 21,059 shares at $0.54 ($12K) on 2022-11-17, disclosed to the SEC on 2022-11-21.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.54 | 4,852 | $3K | 22.3% |
| 2 | $0.56 | 2,500 | $1K | 11.9% |
| 3 | $0.56 | 6,059 | $3K | 28.8% |
| 4 | $0.57 | 7,648 | $4K | 37.0% |
| Total | $0.56 avg | 21,059 | $12K | 100% |
| Filing → |
| LIXT.OB | BUY | 2016-02-19 | $16K | — | Filing → |
| LIXT.OB | BUY | 2016-02-04 | $625 | — | Filing → |